Resumption of review by Anvisa and final deadline from STJ for cultivation define the sector's direction in the first quarter of the year

Partnership with TWA Brands foresees early purchase of products registered with Anvisa and marks the entry of the European company into Brazil

According to Marcelo Polacow Bisson, excluding pharmacies' manipulation leads to lack of assistance; Anvisa's proposed text on the Cannabis regulation is also criticized for bypassing procedural rites

Anvisa authorizations for importing cannabidiol in São Paulo increased by 6.2% between January and July 2025, consolidating the state as a leader in requests and reflecting the expanded access through the SUS

Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay

Published by Anvisa, new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

The Brazilian Association of Cannabinoid Industry (BRcann) forum brought together sector representatives and Anvisa to discuss regulatory updates, research, information, and market

Faced with Anvisa's prohibition on the importation of cannabis flowers, market players diverge in opinions

The decision of Judge Gustavo Müller Lorenzo considers unjust the resolution that differentiates compounding pharmacies from common pharmacies of Anvisa

In a workshop on regulation, Anvisa discusses the use of dietary supplements, including cannabis

With Anvisa's regulation, the use of medical cannabis for animals is starting to gain traction, benefiting the pet sector, veterinary medicine, and the medical cannabis market.

Event brings together experts from ex-Anvisa, Embrapa, and state government to discuss from medical prescription to agricultural potential of hemp

Ministry of Health and Anvisa claim technical complexity and propose a new schedule that extends until March 2026 to define the rules

Court relied on Anvisa resolution to justify favorable opinion

"I am concerned about Anvisa's authorization and now there is this issue. It is a great affliction", reports Rita Carvana, mother of a 13-year-old boy with epilepsy

National mobilization seeks to maintain Anvisa's RDC 660/2022 and avoid risks to the continuity of treatments for thousands of patients

Deadline set by STJ puts pressure on ministries and Anvisa to conclude pending stages of the action plan

Featuring Larissa Meneghel (lawyer and former Anvisa public servant), Paula Scanapieco (Mile Express), and Juliana Sousa (lawyer specialized in customs and criminal law)